- Home
- BODI vs ANVS Comparison
BODI vs ANVS Comparison
Compare BODI & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- ANVS
- Stock Information
- Founded
- BODI 1998
- ANVS 2008
- Country
- BODI United States
- ANVS United States
- Employees
- BODI N/A
- ANVS N/A
- Industry
- BODI Industrial Machinery/Components
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- ANVS Health Care
- Exchange
- BODI Nasdaq
- ANVS Nasdaq
- Market Cap
- BODI 57.9M
- ANVS 53.3M
- IPO Year
- BODI N/A
- ANVS 2020
- Fundamental
- Price
- BODI $8.89
- ANVS $4.88
- Analyst Decision
- BODI Buy
- ANVS Strong Buy
- Analyst Count
- BODI 2
- ANVS 3
- Target Price
- BODI $8.00
- ANVS $13.50
- AVG Volume (30 Days)
- BODI 613.8K
- ANVS 3.6M
- Earning Date
- BODI 11-10-2025
- ANVS 11-12-2025
- Dividend Yield
- BODI N/A
- ANVS N/A
- EPS Growth
- BODI N/A
- ANVS N/A
- EPS
- BODI N/A
- ANVS N/A
- Revenue
- BODI $282,565,000.00
- ANVS N/A
- Revenue This Year
- BODI N/A
- ANVS N/A
- Revenue Next Year
- BODI N/A
- ANVS N/A
- P/E Ratio
- BODI N/A
- ANVS N/A
- Revenue Growth
- BODI N/A
- ANVS N/A
- 52 Week Low
- BODI $3.38
- ANVS $1.11
- 52 Week High
- BODI $10.99
- ANVS $7.39
- Technical
- Relative Strength Index (RSI)
- BODI 68.10
- ANVS 84.99
- Support Level
- BODI $7.44
- ANVS $2.11
- Resistance Level
- BODI $10.99
- ANVS $4.00
- Average True Range (ATR)
- BODI 1.06
- ANVS 0.53
- MACD
- BODI 0.32
- ANVS 0.26
- Stochastic Oscillator
- BODI 64.82
- ANVS 89.56
About BODI The Beachbody Company Inc.
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.